DERM - Dermira, Inc.
Chart Events
Performance Outlook
- Short Term2W - 6W
- Mid Term6W - 9M
- Long Term9M+
| Previous Close | 18.75 |
| Open | 18.75 |
| Bid | 18.70 x 34100 |
| Ask | 18.76 x 38500 |
| Day's Range | 18.74 - 18.77 |
| 52 Week Range | 5.25 - 19.48 |
| Volume | 1,072,156 |
| Avg. Volume | 0 |
| Market Cap | 1.026B |
| Beta (5Y Monthly) | N/A |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings Date | Nov 05, 2019 |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 25.00 |
Fair Value
Related Research
- GuruFocus.com
Largest Insider Trades of the Week
Gurus loaded up on Enterprise Products Partners, dumped Trinet Group Continue reading...
- PR Newswire
Lilly Completes Acquisition of Dermira
Eli Lilly and Company (NYSE: LLY) today announced the successful completion of its acquisition of Dermira, Inc. (NASDAQ: DERM). The acquisition expands Lilly's immunology pipeline with the addition of lebrikizumab, a novel, investigational, monoclonal antibody designed to bind IL-13 with high affinity that is being evaluated in a Phase 3 clinical development program for the treatment of moderate-to-severe atopic dermatitis in adolescent and adult patients, ages 12 years and older. The acquisition of Dermira also expands Lilly's portfolio of marketed dermatology medicines with the addition of QBREXZA® (glycopyrronium), a medicated cloth approved by the FDA for the topical treatment of primary axillary hyperhidrosis (uncontrolled excessive underarm sweating).
- GlobeNewswire
(DERM) Alert: Johnson Fistel Continues Investigation of Proposed Sale of Dermira, Inc. for $19.30
On January 10, 2020, Dermira announced that it had signed a definitive merger agreement with Lilly. The investigation concerns whether the Dermira board failed to satisfy its duties to the Company shareholders, including whether the board adequately pursued alternatives to the acquisition and whether the board obtained the best price possible for Dermira shares of common stock.
- ACCESSWIRE
INVESTOR ALERT: Halper Sadeh LLP Investigates Whether The Sale Of These Companies Is Fair To Shareholders - LOGM, DERM, HXL
NEW YORK, NY / ACCESSWIRE / February 5, 2020 / Halper Sadeh LLP, a global investor rights law firm, continues to investigate the following companies: LogMeIn, Inc. (NASDAQ:LOGM) The investigation concerns ...
- GlobeNewswire
CSFL, DLPH, DERM, and HXL SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Reminds Investors of Investigations of Mergers
WILMINGTON, Del., Feb. 04, 2020 -- Rigrodsky & Long, P.A. announces that it is investigating: CenterState Bank Corporation (NASDAQ GS: CSFL) regarding possible breaches of.
- ACCESSWIRE
SHAREHOLDER ALERT: Halper Sadeh LLP Investigates Whether The Sale Of These Companies Is Fair To Shareholders - HXL, DERM, HABT
NEW YORK, NY / ACCESSWIRE / January 30, 2020 / Halper Sadeh LLP, a global investor rights law firm, continues to investigate the following companies: Hexcel Corporation (NYSE:HXL) The investigation concerns ...
- Zacks
Lilly (LLY) Q4 Earnings and Sales Top Estimates, Stock Up
Eli Lilly's (LLY) Q4 earnings and sales beat estimates. Shares rise in pre-market trading.
- Reuters
Eli Lilly beats profit estimates on strong demand for diabetes drug Trulicity
The drugmaker has been expanding its treatment portfolio and boosting sales of its newer drugs as older medicines including erectile dysfunction treatment Cialis lose market share to cheaper copycats. The results also alleviate investors' "exaggerated concerns" over the launch of Novo Nordisk's once-daily oral diabetes pill, Rybelsus, Citi analyst Andrew Baum said. Rybelsus, approved late last year, is expected to be embraced by patients with an aversion to needles used to deliver treatments such as Trulicity.
- GlobeNewswire
SHAREHOLDER ALERT: WeissLaw LLP Reminds CBB, HABT, DERM, and MFSF Shareholders About Its Ongoing Investigations
WeissLaw LLP is investigating possible breaches of fiduciary duty and other violations of law by the Board of Directors of Cincinnati Bell Inc. (CBB) in connection with the proposed acquisition of the Company by Brookfield Infrastructure Partners L.P. Under the terms of the acquisition agreement, CBB shareholders will receive $10.50 in cash for each CBB share that they own. Weiss Law LLP is investigating possible breaches of fiduciary duty and other violations of law by the Board of Directors of The Habit Restaurants, Inc. (HABT) in connection with the proposed acquisition of the Company by Yum!
- GlobeNewswire
SHAREHOLDER INVESTIGATION: Halper Sadeh LLP Investigates Whether The Sale Of These Companies Is Fair To Shareholders – HABT, DERM, HXL, PRMW
NEW YORK, Jan. 29, 2020 -- Halper Sadeh LLP, a global investor rights law firm, continues to investigate the following companies: The Habit Restaurants, Inc. (NASDAQ: HABT)The.
- GlobeNewswire
PRMW, DERM, HABT, and HXL SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Reminds Investors of Investigations of Mergers
WILMINGTON, Del., Jan. 28, 2020 -- Rigrodsky & Long, P.A. announces that it is investigating: Primo Water Corporation (NASDAQ GS: PRMW) regarding possible breaches of.
- Zacks
Lilly (LLY) to Report Q4 Earnings: What's in the Cards?
Eli Lilly and Company's (LLY) new drugs like Trulicity, Taltz and Jardiance are likely to have performed well. Let's see if these along with older products lead to an earnings beat for the company.
- GlobeNewswire
SHAREHOLDER ALERT: WeissLaw LLP Reminds HABT, DERM, and MFSF Shareholders About Its Ongoing Investigations
WeissLaw LLP is investigating possible breaches of fiduciary duty and other violations of law by the Board of Directors of The Habit Restaurants, Inc. (HABT) in connection with the proposed acquisition of the Company by Yum! Brands, Inc. Under the terms of the acquisition agreement, HABT shareholders will receive $14.00 in cash for each HABT share they own.
- ACCESSWIRE
MERGER ALERT - INST, DERM, and PRMW: Levi & Korsinsky, LLP Reminds Investors of Investigations Concerning the Sale of these Companies
NEW YORK, NY / ACCESSWIRE / January 20, 2020 / The following statement is being issued by Levi & Korsinsky, LLP: Levi & Korsinsky, LLP announces that investigations have commenced on behalf of shareholders ...
- GlobeNewswire
SHAREHOLDER INVESTIGATION: Halper Sadeh LLP Investigates Whether The Sale Of These Companies Is Fair To Shareholders – CBB, HABT, DERM, IBKC
NEW YORK, Jan. 20, 2020 -- Halper Sadeh LLP, a global investor rights law firm, continues to investigate the following companies: Cincinnati Bell Inc. (NYSE: CBB) The.
- Reuters
Eli Lilly targets quarterly deals of $1 billion-$5 billion in 2020 - CFO
Eli Lilly and Co <LLY.N> aims to announce roughly one $1 billion (765 million pounds) to $5 billion (3.8 billion pounds) deal every quarter in 2020, its chief financial officer told Reuters, as the U.S. drugmaker looks to build up its pipeline of future products. It will focus largely on earlier stage opportunities across key therapeutic areas including oncology, pain, immunology, and neurology, CFO John Smiley told Reuters in an interview at the JP Morgan Healthcare conference in San Francisco earlier this week. Eli Lilly has been on a deal-making spree in recent years in a bid to increase products and sales in core franchises as older blockbuster medicines, such as diabetes treatment Humalog, face generic competition and pressure to lower prices.
- GlobeNewswire
DERM, CRCM, LOGM, and WAAS SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Reminds Investors of Investigations of Buyouts
WILMINGTON, Del., Jan. 15, 2020 -- Rigrodsky & Long, P.A. announces that it is investigating: Dermira, Inc. (NASDAQ GS: DERM) regarding possible breaches of fiduciary.
- Thomson Reuters StreetEvents
Edited Transcript of DERM earnings conference call or presentation 5-Nov-19 9:30pm GMT
Q3 2019 Dermira Inc Earnings Call
- PR Newswire
Bragar Eagel & Squire, P.C. Announces that it Is Investigating the Boards of Directors of Dermira, Primo Water, Hexcel, and Pope Resources on behalf of Stockholders and Encourages Investors to Contact the Firm
Bragar Eagel & Squire, P.C. announces to investors that it is investigating potential claims on behalf of stockholders of Dermira, Inc. (NASDAQ: DERM), Primo Water Corporation (NASDAQ: PRMW), Hexcel Corporation (NYSE: HXL), and Pope Resources, A Delaware Partnership (NASDAQ: POPE). Additional information about each potential action can be found at the link provided.
- PR Newswire
Moore Kuehn, PLLC Encourages PRMW, DERM, CBB, and HABT Investors to Contact Firm
Moore Kuehn, PLLC, a securities law firm located on Wall Street in downtown New York City, is investigating potential claims concerning whether the following proposed mergers are fair to shareholders. Shareholders should contact the firm immediately as there may be only a small window of time to enforce your rights:
- ACCESSWIRE
SHAREHOLDER NOTICE: Brodsky & Smith, LLC Announces an Investigation of Dermira, Inc. - (Nasdaq:DERM)
BALA CYNWYD, PA / ACCESSWIRE / January 13, 2020 / Law office of Brodsky & Smith, LLC announces that it is investigating potential claims against the Board of Directors of Dermira, Inc. ("Dermira" ...
- ACCESSWIRE
SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Investors of an Investigation Regarding Whether the Sale of Dermira, Inc. to Eli Lilly and Company is Fair to Shareholders
NEW YORK, NY / ACCESSWIRE / January 13, 2020 / The following statement is being issued by Levi & Korsinsky, LLP: To: All Persons or Entities who purchased Dermira, Inc. ("Dermira" or the "Company") ...
- Zacks
Lilly to Buy Dermira for $1.1B, Add Phase III Eczema Candidate
Lilly (LLY) offers to buy Dermira for $1.1 billion to add the latter's late-stage candidate for atopic dermatitis/eczema, lebrikizumab.
- ACCESSWIRE
SHAREHOLDER INVESTIGATION: Halper Sadeh LLP Investigates Whether The Sale Of These Companies Is Fair To Shareholders - CBB, HABT, DERM
NEW YORK, NY / ACCESSWIRE / January 11, 2020 / Halper Sadeh LLP, a global investor rights law firm, continues to investigate the following companies: Cincinnati Bell Inc. (NYSE:CBB) The investigation concerns ...
